A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...

Schizophrenia, bipolar disorder, major depressive disorder and other severe mental illnesses affect a greater proportion of patients with chronic kidney disease (CKD).

Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors ...

As of mid-May, this variant has been identified in nearly 11% of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently assesses the ...

A randomized controlled trial tested the efficacy and safety of a silicone-covered metallic stent compared with a conventional polymeric double-J stent in patients with malignant ureteral obstruction.

Pizza, soup, chicken were top sources of sodium across racial, ethnic groups; top four sources were different for Asian Americans ...

To better compare belimumab’s efficacy with results from phase 3 trials of obinutuzumab, investigators conducted a post hoc analysis of patients with active proliferative lupus nephritis in the MMF ...

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.

These changes are meant to limit the use of the shots while experts collect more data on how well they work for healthy people. (HealthDay News) — The U.S. Food and Drug Administration (FDA) has ...

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

Outpatients with cancer had a significantly higher risk of developing MRSA and antimicrobial-resistant Pseudomonas aeruginosa, Enterobacterales, and Enterococcus species. New research suggests ...

A subset of patients receiving triple immunosuppressive therapy with voclosporin, mycophenolate mofetil, and low-dose glucocorticoids can achieve lower proteinuria targets.